Exercise to Boost Response to Checkpoint Blockade Immunotherapy (clinicaltrials.gov) - Sep 16, 2026 - P1 | N=22 | Active, not recruiting | Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Trial completion date: Aug 2026 ➔ Aug 2027
Checkpoint inhibition • IO biomarker • Trial completion date • Cutaneous Melanoma • Melanoma • Merkel Cell Carcinoma • Oncology • Skin Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Skin Cancer
|